Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Issac Nunez Killed in Crash on Interstate 210 Near Highway 330


3 Vehicles Involved in Fatal Highland Accident

Fatal Accident 5

Highland, CA (February 9, 2020) – A man was killed in a multi-vehicle crash in Highland. The fatal accident occurred on the evening of February 9 on Interstate 210. 

A Honda sedan and another sedan collided on Interstate 210, near Highway 330. The impact caused the sedan to crash into a guardrail. A Toyota Tundra and another vehicle were also involved. San Bernardino resident Issac Nunez, 23, died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of Issac Nunez.

#Highland

#92346


May 26, 2020

2 Killed, 1 Injured in Crash on La Palma Avenue

Driver Arrested for DUI in Fatal Anaheim Accident...


November 4, 2019

Raihan Dakhil, Joseph Awaida, Omar Killed in Pedestrian Crash at Country Club Drive and Los Cerritos Park Place

Carlo Navarro Out on Bail After Causing Fatal Long Beach Accident...


April 20, 2020

Man Injured in Crash on Highway 168 Near Herndon Avenue

Car Hits Wall, Overturns in Clovis Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.